1.Efficacy of new hydrogel for repair of chronic infectious skin wounds in diabetic rats
Suiou LI ; Minghan LI ; Zhaobo ZHU ; Hui ZENG ; Yunchuan BAI
Chinese Journal of Nosocomiology 2025;35(19):2896-2900
OBJECTIVE This study evaluates the role of Gelation metnacrylate(GelMA)hydrogel loaded with hPT H(3-34)(29-34)short peptide in the healing of chronic infectious skin wounds in diabetic rats.METHODS Ex-perimental rats were divided into control group,GelMA group and GelM A+hPTH(3-34)(29-34)group,with 15 rats in each group.Diabetic rat models were prepared,and chronic infectious skin wounds were constructed.Differences in wound area changes,wound healing-related indicator[type Ⅰ collagen α1 chain(COL1A1),α-smooth muscle actin(α-SMA),platelet endothelial cell adhesion molecule-1(CD31),matrix metalloproteinase-9(MMP9)and cyclooxygenase-2(Cox2)]expression and migration ability of fibroblasts in vitro were compared a-mong the groups.RESULTS Compared with the control group,the wound area of rats in the GelMA group de-creased on Day 7 and Day 14(P<0.05),and the wound area of rats in the GelM A+hPTH(3-34)(29-34)group decreased on Day 3,Day 7 and Day 14(P<0.05).Compared with the GelMA group,the wound area of rats in the GelM A+hPTH(3-34)(29-34)group decreased on Day 3,Day 7 and Day 14(P<0.05).Compared with the control group,on Day 7 after modeling,the expression of COL1A1,α-SMA and CD31 in rats was upregulated,and in the GelM A+hPTH(3-34)(29-34)group showed a greater increase than in the GelMA group(P<0.05),while the expression of MMP9 and Cox2 was downregulated,and in the GelMA+hPTH(3-34)(29-34)group showed a greater decrease than in the GelMA group(P<0.05).Compared with the control group,on Day 7 af-ter modeling,the relative activity of NLRP3,IL-6,TNF-α,IL-1β and Caspase-1 in rats decreased,and in the GelM A+hPTH(3-34)(29-34)group showed a greater decrease than in the GelMA group(P<0.05).On Day 7 after modeling,the relative scratch distance of fibroblasts derived from the wound tissue in the GelMA+h PT H(3-34)(29-34)group was greater than that in the GelMA group,which was greater than that in the control group(P<0.05).CONCLUSIONS The GelMA hydrogel loaded with hPTH(3-34)(29-34)short peptide can effectively accelerate the wound healing process and enhance tissue repair and structural reconstruction by inhibiting the activ-ity of the NLRP3 inflammasome pathway,demonstrating its potential to improve wound healing efficiency.
2.Efficacy of new hydrogel for repair of chronic infectious skin wounds in diabetic rats
Suiou LI ; Minghan LI ; Zhaobo ZHU ; Hui ZENG ; Yunchuan BAI
Chinese Journal of Nosocomiology 2025;35(19):2896-2900
OBJECTIVE This study evaluates the role of Gelation metnacrylate(GelMA)hydrogel loaded with hPT H(3-34)(29-34)short peptide in the healing of chronic infectious skin wounds in diabetic rats.METHODS Ex-perimental rats were divided into control group,GelMA group and GelM A+hPTH(3-34)(29-34)group,with 15 rats in each group.Diabetic rat models were prepared,and chronic infectious skin wounds were constructed.Differences in wound area changes,wound healing-related indicator[type Ⅰ collagen α1 chain(COL1A1),α-smooth muscle actin(α-SMA),platelet endothelial cell adhesion molecule-1(CD31),matrix metalloproteinase-9(MMP9)and cyclooxygenase-2(Cox2)]expression and migration ability of fibroblasts in vitro were compared a-mong the groups.RESULTS Compared with the control group,the wound area of rats in the GelMA group de-creased on Day 7 and Day 14(P<0.05),and the wound area of rats in the GelM A+hPTH(3-34)(29-34)group decreased on Day 3,Day 7 and Day 14(P<0.05).Compared with the GelMA group,the wound area of rats in the GelM A+hPTH(3-34)(29-34)group decreased on Day 3,Day 7 and Day 14(P<0.05).Compared with the control group,on Day 7 after modeling,the expression of COL1A1,α-SMA and CD31 in rats was upregulated,and in the GelM A+hPTH(3-34)(29-34)group showed a greater increase than in the GelMA group(P<0.05),while the expression of MMP9 and Cox2 was downregulated,and in the GelMA+hPTH(3-34)(29-34)group showed a greater decrease than in the GelMA group(P<0.05).Compared with the control group,on Day 7 af-ter modeling,the relative activity of NLRP3,IL-6,TNF-α,IL-1β and Caspase-1 in rats decreased,and in the GelM A+hPTH(3-34)(29-34)group showed a greater decrease than in the GelMA group(P<0.05).On Day 7 after modeling,the relative scratch distance of fibroblasts derived from the wound tissue in the GelMA+h PT H(3-34)(29-34)group was greater than that in the GelMA group,which was greater than that in the control group(P<0.05).CONCLUSIONS The GelMA hydrogel loaded with hPTH(3-34)(29-34)short peptide can effectively accelerate the wound healing process and enhance tissue repair and structural reconstruction by inhibiting the activ-ity of the NLRP3 inflammasome pathway,demonstrating its potential to improve wound healing efficiency.
3.Prevention and treatment of hepatic artery dissection in donors and recipients during liver transplantation
Zhaobo LIU ; Zhenshun WANG ; Dongbin LIU ; Fei LI ; Jia LI ; Dongdong LIN
Organ Transplantation 2023;14(4):498-
Hepatic artery reconstruction is one of the key procedures in liver transplantation. Accidental dissection of the hepatic artery to be reconstructed caused by donor and recipient factors or surgical factors will disrupt the surgical plan, increase the difficulty of arterial reconstruction, significantly prolong the operation time, increase the risk of postoperative arterial stenosis and thrombosis and probably lead to acute allograft failure, which requires emergency surgical interventions or even secondary liver transplantation. Understanding of how to avoid dissection of the artery to be anastomosed during liver transplantation and corresponding treatment will contribute to preventing the incidence of artery-related complications during liver transplantation and improving clinical prognosis of liver transplant recipients. In this article, the causes, prevention and treatment of hepatic artery dissection and hepatic artery reconstruction in donors and recipients during liver transplantation were illustrated.
4.Protective Effect of Wenxin Prescription on Mitochondrial Energy Metabolism in Rats with Myocardial Ischemia-reperfusion Injury
Ying LIU ; Zhaobo WANG ; Li SHEN ; Hongxin CAO
Chinese Journal of Experimental Traditional Medical Formulae 2022;28(17):52-59
ObjectiveTo reveal the effect of Wenxin prescription on mitochondrial energy metabolism and silent information regulator 1 (SIRT1)/peroxisome proliferator-activated receptor-γ coactivator-1α (PGC-1α)/recombinant estrogen-related receptor α (ERRα) signaling pathway in rats with myocardial ischemia-reperfusion injury. MethodTotally 90 male Wistar rats of SPF grade were randomly assigned into a sham operation group, a model group, and low-, medium-, and high-dose Wenxin prescription groups, with 18 rats in each group. The rats in low-, medium-, and high-dose Wenxin prescription groups were administrated with 0.99, 1.98, and 3.96 g·kg-1 granules by gavage, respectively, and those in the sham operation group and model group with the same amount of normal saline. Twenty-one days after pre-administration, the rat model of myocardial ischemia-reperfusion injury was established by ligation of the left anterior descending coronary artery for 30 min and reperfusion for 2 h, and the rats in the sham operation group were only threaded without ligation. Myocardial infarction area was observed through 2,3,5-triphenyl-2h-tetrazolium chloride (TTC) staining, and the myocardial histopathology through hematoxylin-eosin (HE) staining. The levels of creatine kinase-MB (CK-MB) and lactate dehydrogenase (LDH) in serum, cytochrome C oxidase (CCO) and succinate dehydrogenase (SDH) in mitochondrion, and ATP in myocardial tissue were detected according to kit instructions. The mRNA and protein levels of SIRT1, PGC-1α, ERRα, and mitochondrial transcription factor A (TFAM) in myocardial tissue were determined by Real-time fluorescence quantitative polymerase chain reaction (Real-time PCR) and Western blot, respectively. ResultCompared with the sham operation group, the model group showed broken and disordered myocardial fibers, cytoplasmic edema, and pyknosis and deviation of nuclei. Moreover, the modeling increased the levels of CK-MB and LDH (P<0.05, P<0.01), lowered the levels of ATP, CCO, and SDH (P<0.05, P<0.01), and down-regulated the mRNA and protein levels of SIRT1, PGC-1α, ERRα, and TFAM in myocardial tissue (P<0.05, P<0.01). Compared with the model group, Wenxin prescription reduced the myocardial infarction area (especially in the high-dose group, P<0.01), restored the pathological changes, lowered the levels of CK-MB and LDH (P<0.05, P<0.01), increased the levels of ATP, CCO, and SDH (especially in the high-dose group, P<0.01), and up-regulated the mRNA and protein levels of SIRT1, PGC-1α, ERRα, and TFAM in myocardial tissue (P<0.05, P<0.01). ConclusionWenxin prescription can protect rats from myocardial ischemia-reperfusion injury by regulating myocardial mitochondrial energy metabolism via the SIRT1/PGC-1α/ERRα signaling pathway.
5.Consistency of peripheral whole blood and venous serum procalcitonin in children: a multicenter parallel controlled study
Quan LU ; Hong ZHANG ; Xiaoyan DONG ; Hanmin LIU ; Yongmei JIANG ; Yingxue ZOU ; Yongming SHEN ; Deyu ZHAO ; Hongbing CHEN ; Tao AI ; Chenggui LIU ; Zhaobo SHEN ; Junmei YANG ; Yuejie ZHENG ; Yunsheng CHEN ; Weigang CHEN ; Yefei ZHU ; Chonglin ZHANG ; Lijun TIAN ; Guorong WU ; Ling LI ; Aibin ZHENG ; Meng GU ; Yongyue WEI ; Liangmin WEI
Chinese Journal of Pediatrics 2021;59(6):471-477
Objective:To explore the consistency of peripheral whole blood and venous serum procalcitonin (PCT) levels, and the value of peripheral whole blood PCT in evaluating pediatric bacterial infection.Methods:This multicenter cross-sectional parallel control study was conducted in 11 children′s hospital. All the 1 898 patients older than 28 days admitted to these hospitals from March 2018 to February 2019 had their peripheral whole blood and venous serum PCT detected simultaneously with unified equipment, reagent and method. According to the venous serum PCT level, the patients were stratified to subgroups. Analysis of variance and chi-square test were used to compare the demographic characteristics among groups. And the correlation between the peripheral blood and venous serum PCT level was investigated by quantitative Pearson correlation analysis.The PCT resultes were also converted into ranked data to further test the consistency between the two sampling methods by Spearman′s rank correlation test. Furthermore, the ranked data were converted into binary data to evaluate the consistency and investigate the best cut-off of peripheral blood PCT level in predicting bacterial infection.Results:A total of 1 898 valid samples were included (1 098 males, 800 females),age 27.4(12.2,56.7) months. There was a good correlation between PCT values of peripheral whole blood and venous serum ( r=0.97 , P<0.01). The linear regression equation was PCT?venous serum=0.135+0.929×PCT peripheral whole blood. However, when stratified to 5 levels, PCT results showed diverse and unsatisfied consistency between the two sampling methods ( r=0.51-0.92, all P<0.01). But after PCT was converted to ordinal categorical variables, the stratified analysis showed that the coincidence rate of the measured values by the two sampling methods in each boundary area was 84.9%-97.1%. The dichotomous variables also showed a good consistency (coincidence rate 96.8%-99.3%, Youden index 0.82-0.89). According to the severity of disease, the serum PCT value was classified into 4 intervals(<0.5、0.5-<2.0、2.0-<10.0、≥10.0 μg/L), and the peripheral blood PCT value also showed a good predictive value (AUC value was 0.991 2-0.997 9). The optimal cut points of peripheral whole blood PCT value 0.5、1.0、2.0、10.0 μg/L corresponding to venous serum PCT values were 0.395, 0.595, 1.175 and 3.545 μg/L, respectively. Conclusions:There is a good correlation between peripheral whole blood PCT value and the venous serum PCT value, which means that the peripheral whole blood PCT could facilitate the identification of infection and clinical severity. Besides, the sampling of peripheral whole blood is simple and easy to repeat.
6.Safety of PD-1 inhibitor in preoperative treatment of liver transplantation for liver cancer
Zhaobo LIU ; Jushan WU ; Dongdong LIN ; Guangming LI
Organ Transplantation 2021;12(4):445-
Objective To evaluate the safety of programmed cell death protein 1 (PD-1) inhibitor in the treatment of primary liver cancer (liver cancer) before liver transplantation. Methods Clinical data of 7 recipients given with PD-1 inhibitor before liver transplantation for liver cancer were retrospectively analyzed. The incidence of immune-related adverse event (irAE) and clinical prognosis of the recipients were summarized. The safety of PD-1 inhibitor in recipients prior to liver transplantation for liver cancer was evaluated. Results Seven recipients were treated with PD-1 inhibitor with 1-20 courses before liver transplantation for liver cancer. The time interval from drug withdrawal to liver transplantation was 6-120 d. Five recipients suffered from irAE of different degrees, including fatigue in 3 cases, fever in 2 cases, alopecia in 2 cases, rash in 1 case, nausea in 1 case and myocarditis in 1 case, respectively. A majority of these irAE were classified as grade Ⅰ-Ⅱ. One recipient died from grade Ⅴ irAE (fatal myocarditis). One recipient developed rejection at postoperative 7 d, which were mitigated after glucocorticoid pulse therapy combined with increased dosage of tacrolimus. Conclusions PD-1 inhibitor can be applied in preoperative treatment before liver transplantation for liver cancer. Nevertheless, the incidence of irAE and postoperative rejection should be intimately monitored.
7.Advances in the prevention and treatment of hepatocellular carcinoma recurrence after liver transplantation
Journal of Clinical Hepatology 2021;37(2):267-271
Liver transplantation is an effective radical treatment method for patients with hepatocellular carcinoma (HCC), but HCC recurrence after liver transplantation seriously affects the long-term survival of patients receiving transplantation. Active preventive measures, adjustment of immunosuppressant, early identification of HCC recurrence, and development of comprehensive intervention measures after recurrence can help to improve the clinical outcome and long-term survival of HCC patients receiving liver transplantation. In order to further improve the prognosis of patients receiving liver transplantation, this article summarizes the latest research advances in the prevention and treatment of HCC recurrence after liver transplantation from the aspects of recurrence prevention and treatment after recurrence.
8.Role of live webcast as a new medium in the propaganda and education of liver transplant recipients
Xiaofei ZHAO ; Binwei DUAN ; Zhaobo LIU ; Jing ZHANG ; Qingliang GUO ; Guangming LI
Organ Transplantation 2020;11(6):719-
Objective To evaluate the role of live webcast as a new medium in the propaganda and education of liver transplant recipients. Methods According to the contents of live webcast propaganda and education meeting for liver transplant recipients, relevant data of the live webcast meeting were counted and analyzed, including baseline data of participants, participation pattern, viewing frequency and duration, etc. The characteristics between live webcast and traditional propaganda and education meetings were compared. Results By the end of the live webcast meeting, 273 participants were registered, including 2 oversea participants and 271 from China. These domestic participants were from 26 provinces, autonomous regions and municipalities in China. The total number of views was 1 526. Participants attended the meeting by clicking direct link (
9.The impact of splenectomy and esophagogastric devascularization on the nutrition status of patients with cirrhosis and portal hypertension
Daobing ZENG ; Chun ZHANG ; Liang DI ; Daming GAO ; Binwei DUAN ; Haitao ZHANG ; Qingliang GUO ; Qinghua MENG ; Lei LI ; Juan LI ; Xiaofei ZHAO ; Jushan WU ; Dongdong LIN ; Yunjin ZANG ; Zhaobo LIU ; Libo SUN ; Shichun LU
Chinese Journal of Hepatobiliary Surgery 2017;23(7):437-440
Objective To study the impact of splenectomy and esophagogastric devascularization on the nutritional status of patients with cirrhosis and portal hypertension.Methods Sixty consecutive patients with cirrhosis and portal hypertension who underwent splenectomy and esophagogastric devascularization at the Beijing YouAn Hospital from April 5,2015 to January 23,2017 were included in this study.The body mass index (BMI),albumin (Alb),prealbumin (PA) and lymphocyte counts were prospectively collected at the end of 1-week,1-month,3-month,6-month and 1-year after surgery.The postoperative results were compared with the preoperative results in these patients.Results The BMI results obtained at 1-week and 1-month after surgery were significantly lower than the preoperative level [(22.14 ± 3.08)kg/m2 vs.(22.85 ± 3.14) kg/m2,(21.72 ± 3.05) kg/m2 vs.(22.86 ± 3.16) kg/m2,P < 0.05].The BMI result at the end of 1-year after surgery was significantly elevated when compared with the preoperative level [(23.24 ± 3.64) kg/m2 vs.(22.68 ± 3.47) kg/m2,P < 0.05].The ALB levels at 1-month and 3-month after surgery were significantly higher than the preoperative level [(39.87 ± 4.22)g/L vs.(35.35 ±5.15) g/L,(39.35 ± 4.75) g/L vs.(34.82 ± 5.50) g/L,P < 0.05].The PA obtained at 1-week after surgery was significantly lower than the preoperative levels [(79.59 26.52)mg/L vs.(121.77 ±39.96)mg/L,P < 0.05].The lymphocyte counts at all the points after surgery were significantly higher than the preoperative level (P < 0.05).Conclusion Short term and long term nutritional status improved in patients with cirrhosis and portal hypertension after splenectomy and esophagogastric devascularization.

Result Analysis
Print
Save
E-mail